Proteomic Mapping of the Interactome of KRAS Mutants Identifies New Features of RAS Signalling Networks and the Mechanism of Action of Sotorasib

Aoife Nolan, Cinzia Raso, Walter Kolch, Alexander von Kriegsheim, Kieran Wynne, David Matallanas*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract / Description of output

RAS proteins are key regulators of cell signalling and control different cell functions including cell proliferation, differentiation, and cell death. Point mutations in the genes of this family are common, particularly in KRAS. These mutations were thought to cause the constitutive activation of KRAS, but recent findings showed that some mutants can cycle between active and inactive states.
This observation, together with the development of covalent KRASG12C inhibitors, has led to the arrival of KRAS inhibitors in the clinic. However, most patients develop resistance to these targeted therapies, and we lack effective treatments for other KRAS mutants. To accelerate the development of RAS targeting therapies, we need to fully characterise the molecular mechanisms governing KRAS signalling networks and determine what differentiates the signalling downstream of the KRAS mutants. Here we have used affinity purification mass-spectrometry proteomics to characterise the interactome of KRAS wild-type and three KRAS mutants. Bioinformatic analysis associated
with experimental validation allows us to map the signalling network mediated by the different KRAS proteins. Using this approach, we characterised how the interactome of KRAS wild-type and mutants is regulated by the clinically approved KRASG12C inhibitor Sotorasib. In addition, we identified novel crosstalks between KRAS and its effector pathways including the AKT and JAK-STAT signalling modules
Original languageEnglish
JournalCancers
Volume15
Issue number16
Early online date17 Aug 2023
DOIs
Publication statusPublished - 17 Aug 2023

Keywords / Materials (for Non-textual outputs)

  • KRAS
  • proteomics
  • JAK1
  • RADIL
  • Sotorasib
  • SOS1

Fingerprint

Dive into the research topics of 'Proteomic Mapping of the Interactome of KRAS Mutants Identifies New Features of RAS Signalling Networks and the Mechanism of Action of Sotorasib'. Together they form a unique fingerprint.

Cite this